Adimmune Corp revenue rises to NT$97.9M for Aug; prior NT$72.8M
Adimmune Corp reports August revenue of NT$97,916,000 versus NT$72,821,000 in 2025. January–August revenue is NT$555,205,000 versus NT$493,239,000 in 2025, per Taiwan Stock Exchange figures.